Demonstrates structural conservation of the pore structure between prokaryotic and eukaryotic K+ channels, offering a new approach for K+ channel pharmacology.
Answers are grounded in this paper and cite their sources.
Bacterial K+ channel models may aid drug design; leaves open translation to human cardiovascular therapies.
Toxins from scorpion venom interact with potassium channels. Resin-attached, mutant K+ channels from Streptomyces lividans were used to screen venom from Leiurus quinquestriatus hebraeus, and the toxins that interacted with the channel were rapidly identified by mass spectrometry. One of the toxins, agitoxin2, was further studied by mutagenesis and radioligand binding. The results show that a prokaryotic K+ channel has the same pore structure as eukaryotic K+ channels. This structural conservation, through application of techniques presented here, offers a new approach for K+ channel pharmacology.
No takes yet. Share an insight, caveat, or question.
MacKinnon et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: